Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Quva acquires CAPS' 503B Product Portfolio

PRIVATESep 08, 2026about 3 hours ago

Acquiring Company

QuVa Pharma

Acquired Company

Central Admixture Pharmacy Services

Sugar LandBethesdaBiotechnologyHealth CarePharmaceuticalOther

Description

Quva Pharma, Inc. has acquired a range of essential medications from Central Admixture Pharmacy Services, Inc. as CAPS exits the 503B sterile compounding business. This acquisition is aimed at maintaining the supply of critical medications to U.S. hospitals. Quva plans to introduce selected products from the portfolio in phases later in 2026.

Company Information

Company

QuVa Pharma

Location

Sugar Land, Texas, United States

About

QuVa Pharma, Inc. is a national scale market-leading sterile compounding services and direct distribution capabilities company. It is the largest 503B Outsourcing company serving U.S. hospitals and health systems, and provides integrated healthcare solutions in the pharmaceutical industry.

Don't miss QuVa Pharma's next move

Get an email the moment QuVa Pharma makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Stuart
Likely contact at this company
••••••••@••••••••

See Stuart's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for QuVa Pharma's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Central Admixture Pharmacy Services?

Central Admixture Pharmacy Services was acquired by QuVa Pharma, based in Sugar Land. The deal was reported on September 8, 2026. QuVa Pharma, Inc. is a national scale market-leading sterile compounding services and direct distribution capabilities company. It is the largest 503B Outsourcing company serving U.S. QuVa Pharma is privately held and operates in Biotechnology.

When did QuVa Pharma acquire Central Admixture Pharmacy Services?

QuVa Pharma's acquisition of Central Admixture Pharmacy Services was reported on September 8, 2026. Quva Pharma, Inc. has acquired a range of essential medications from Central Admixture Pharmacy Services, Inc. as CAPS exits the 503B sterile compounding business. This acquisition is aimed at maintaining the supply of critical medications to U.S. hospitals. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Central Admixture Pharmacy Services do?

Central Admixture Pharmacy Services is the company acquired in this transaction. It is privately held, operating in Other, and is based in Bethesda.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.